Literature DB >> 16913837

PREPL: a putative novel oligopeptidase propelled into the limelight.

Kevin Martens1, Rita Derua, Sandra Meulemans, Etienne Waelkens, Jaak Jaeken, Gert Matthijs, John W M Creemers.   

Abstract

The prolyl endopeptidase-like protein PREPL has recently attracted attention because its gene is located within two contiguous gene-deletion syndromes, the 2p21 deletion syndrome and the hypotonia-cystinuria syndrome. Deletion of the gene results in hypotonia at birth, failure to thrive and growth hormone deficiency. PREPL is highly reactive against an activity-based probe, which indicates the presence of an intact catalytic machinery. However, no substrate has been found yet. The unique carboxy-terminus of the catalytic domain might contain the key to the as yet elusive specificity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913837     DOI: 10.1515/BC.2006.111

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  17 in total

Review 1.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

2.  PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.

Authors:  Luc Régal; Xin-Ming Shen; Duygu Selcen; Chantal Verhille; Sandra Meulemans; John W M Creemers; Andrew G Engel
Journal:  Neurology       Date:  2014-03-07       Impact factor: 9.910

Review 3.  Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.

Authors:  Lloyd D Fricker
Journal:  Mol Biosyst       Date:  2010-04-28

4.  Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.

Authors:  B Chabrol; K Martens; S Meulemans; A Cano; J Jaeken; G Matthijs; J W M Creemers
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  The unfolding landscape of the congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen
Journal:  Ann N Y Acad Sci       Date:  2018-01-21       Impact factor: 5.691

6.  A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.

Authors:  Anna Mari Lone; Daniel A Bachovchin; David B Westwood; Anna E Speers; Timothy P Spicer; Virneliz Fernandez-Vega; Peter Chase; Peter S Hodder; Hugh Rosen; Benjamin F Cravatt; Alan Saghatelian
Journal:  J Am Chem Soc       Date:  2011-07-12       Impact factor: 15.419

Review 7.  Peptidomics methods for the identification of peptidase-substrate interactions.

Authors:  Anna Mari Lone; Yun-Gon Kim; Alan Saghatelian
Journal:  Curr Opin Chem Biol       Date:  2013-01-15       Impact factor: 8.822

8.  Peptidomics of prolyl endopeptidase in the central nervous system.

Authors:  Whitney M Nolte; Debarati M Tagore; William S Lane; Alan Saghatelian
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

9.  PREPL deficiency: delineation of the phenotype and development of a functional blood assay.

Authors:  Luc Régal; Emma Mårtensson; Isabelle Maystadt; Nicol Voermans; Damien Lederer; Alberto Burlina; María Jesús Juan Fita; A Jeannette M Hoogeboom; Mia Olsson Engman; Tess Hollemans; Meyke Schouten; Sandra Meulemans; Tord Jonson; Inge François; David Gil Ortega; Erik-Jan Kamsteeg; John W M Creemers
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

Review 10.  Inherited disorders of the neuromuscular junction: an update.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; David Beeson
Journal:  J Neurol       Date:  2014-10-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.